Skip to main content
SpringerLink
Log in

Consensus guidelines on acute drug-induced liver injury in trials

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Treem WR, et al. Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis. Drug Safety : 3 Nov 2020. Available from: URL: https://doi.org/10.1007/s40264-020-01014-2

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Consensus guidelines on acute drug-induced liver injury in trials. Reactions Weekly 1829, 9 (2020). https://doi.org/10.1007/s40278-020-85599-0

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-020-85599-0

Search

Navigation